Previous close | 5.0000 |
Open | 5.0000 |
Bid | 3.6000 |
Ask | 8.5000 |
Strike | 62.50 |
Expiry date | 2024-10-18 |
Day's range | 5.0000 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats